UT Southwestern Medical Center
Pathology residency · Dallas, TX · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is The University of Texas Southwestern Medical Center's research in pathology, which the program shares with other departments and affiliated hospitals.
About The University of Texas Southwestern Medical Centerinstitution-wide pathology research
Pathology publications from The University of Texas Southwestern Medical Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
100
works per year
7th of 65 pathology residency programs
+7.3%
2-year growth
33rd of 65 pathology residency programs
20.7%
in top 10% of field (works before 2025)
24th of 56 pathology residency programs
47.4%
cited above world average
12th of 56 pathology residency programs
Works per year · * 2026 so far
Pathology and Forensic Medicine · 501
Pathology research topics at The University of Texas Southwestern Medical Center
Papers in the window; each links to the list on OpenAlex.
- Multiple Sclerosis Research Studies 180
- Lymphoma Diagnosis and Treatment 82
- Alcohol Consumption and Health Effects 39
- Breast Lesions and Carcinomas 35
- Spine and Intervertebral Disc Pathology 31
- Systemic Sclerosis and Related Diseases 30
- Genetic factors in colorectal cancer 21
- Spinal Cord Injury Research 20
Most cited at The University of Texas Southwestern Medical Center since 2024
All pathology papers there on OpenAlex
- Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In OncologyRachel Hodan et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 126
- Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne Haney Cross et al. · JAMA Neurology · 2024 · PubMed · cited 107
- Impact of population screening for Lynch syndrome insights from the All of Us dataJiheum Park et al. · Nature Communications · 2025 · PubMed · cited 98
- Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitisSamer Gawrieh et al. · Journal of Hepatology · 2024 · PubMed · cited 65
- Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus StatementBrian P. Lee et al. · Nature Reviews Gastroenterology & Hepatology · 2024 · PubMed · cited 64
- Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trialWon Seog Kim et al. · Nature Cancer · 2025 · PubMed · cited 61
- Comorbidity and Disease Activity in Multiple SclerosisAmber R. Salter et al. · JAMA Neurology · 2024 · PubMed · cited 57
- Advancing multiple sclerosis management in older adultsAnneke van der Walt et al. · Nature Reviews Neurology · 2025 · PubMed · cited 40
- Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysisSimon Arnett et al. · Journal of Neurology · 2024 · PubMed · cited 39
- The Evolution of Anti-CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and FunctionBruce Cree et al. · CNS Drugs · 2025 · PubMed · cited 35